The Role of hCG in Thawed Embryo Transfer

Recruiting now · Phase 4

Conditions studied: Infertility (IVF Patients)

In brief

This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

Key facts

Study ID

NCT07004192

Run by

Fertility Center of Las Vegas

People needed

220

Starts

2025-06-02

Expected to finish

2027-12-31

Last updated by the study team

2025-07-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female adult expecting to receive transfer of a thawed embryo.
• At least one available frozen blastocyst of transferrable quality.
• Non-menopausal female with at least one antral follicle.
• Use of pre-implantation genetic testing (PGT), embryos derived from donor oocytes and/or donor sperm, a gestational carrier, and history of prior transfer(s) regardless of outcome are allowed.
• Subsequent embryo transfers after failed transfers under this study are allowed, but not after a transfer that has resulted in ongoing pregnancy at ten weeks gestation under this study.

You may not qualify if…

• Minors (age<18 years).
• Use of embryo(s) frozen at another center.
• Patient insistent on transfer of two embryos.
• Patient or partner unable to provide informed consent in English.
• Patient already enrolled in any other research study for her embryo transfer.
• History of anti-phospholipid syndrome or any other indication for use of Lovenox in pregnancy.
• Patient for whom the physician assesses this protocol is inappropriate or unsafe.

Where it is running

• Fertility Center of Las Vegas — Las Vegas, Nevada, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.